Mouse Models for Multiple Sclerosis

-
Introduction: For complex diseases like multiple sclerosis (MS), animal models are highly important because they allow researchers to systematically study numerous factors which contribute to the disease in ways that are not possible in human patients. Animal models also serve as testing arenas for potential treatments. However, the disease complexity which makes animal models so necessary also means that animal models are only able to reflect some aspects of human MS.

Induced Models

Experimental autoimmune encephalomyelitis (EAE) is the oldest model of demyelinating diseases (1), and has led to the discovery of human therapies for MS, but EAE has shortcomings that make it difficult to connect findings from the animal model to the human disease, particularly with respect to drug testing (2). To induce EAE, researchers stimulate a T-cell-mediated immune response against myelin, which leads to an inflammatory response in the CNS, and demyelination. Not only is the pathophysiology of EAE potentially very different from MS, but since EAE is an induced model, the data is highly dependent on how the experiment is performed (3).

Viral Models

Epstein-Barr virus (EBV) infection has been identified as an environmental factor linked to MS susceptibility, and it is likely that other viruses can contribute as well (4,5). Many researchers have used Theiler’s murine encephalomyelitis virus (TMEV) intracerebral injections to cause demyelinating disease in mice. Despite being virally-induced, the pathology of these models is mediated by the immune system, not by direct viral effects. Also, the disease course is similar to that observed in chronic progressive MS, making these viral models valuable for studying MS (6).

Genetic Models

Transgenic mice have come to the forefront of MS research. Unlike previous animal models, some transgenic mouse models can spontaneously develop demyelinating disease, thereby mimicking a key aspect of MS. Two groups independently generated nearly identical double-transgenic mouse models that express both T-cell and B-cell receptors both recognizing myelin oligodendrocyte glycoprotein (MOG) (7-9). About half of these mice spontaneously develop an MS-like disease.

Humanized mouse models have also become powerful MS models in recent years. For example, mice expressing MS-associated versions of human leukocyte antigen (HLA) genes can be used in EAE induction experiments, and results can be translated more directly to MS in humans (10).

Reference

  1. Wolf A, Kabat EA, Bezer AE. (1947) The pathology of acute disseminated encephalomyelitis produced experimentally in the rhesus monkey and its resemblance to human demyelinating disease. J Neuropathol Exp Neurol. 6:333-57.
  2. Sriram S, Steiner I. (2005) Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol. 58:939-45.
  3. Amor S, Baker D. (2012) Checklist for reporting and reviewing studies of experimental animal models of multiple sclerosis and related disorders. Mult Scler Relat Disord. 1:111-5.
  4. De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. (2008) Integrating risk factors: HLA-DRB1* 1501 and Epstein-Barr virus in multiple sclerosis. Neurology. 70:1113–1118.
  5. Ascherio A, Munger KL. (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 61:288–299.
  6. Denic A, Johnson AJ, Bieber AJ, Warrington AE, Rodriguez M, Pirko I. (2011) The relevance of animal models in multiple sclerosis research. Pathophysiology. 18:21-9.
  7. Ransohoff RM. (2006) A mighty mouse: building a better model of multiple sclerosis. J Clin Invest. 116:2313-6.
  8. Krishnamoorthy G, Lassmann H, Wekerle H, Holz A. (2006) Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J Clin Invest. 116:2385-92.

Original Source: Cyagen Biosciences (www.cyagen.com)

Comments

Post a Comment

Popular posts from this blog

Cells driving gecko's ability to re-grow its tail identified

-
Image
A U of G researcher is the first to discover the type of stem cell that is behind the gecko's ability to re-grow its tail, a finding that has implications for spinal cord treatment in humans. Many lizards can detach a portion of their tail to avoid a predator and then regenerate a new one. Unlike mammals, the lizard tail includes a spinal cord. Prof. Matthew Vickaryous found that the spinal cord of the tail contained a large number of stem cells and proteins known to support stem cell growth. "We knew the gecko's spinal cord could regenerate, but we didn't know which cells were playing a key role," said Vickaryous, lead author of the study recently published in the  Journal of Comparative Neurology . "Humans are notoriously bad at dealing with spinal cord injuries so I'm hoping we can use what we learn from geckos to coax human spinal cord injuries into repairing themselves." Geckos are able to re-grow a new tail within 30 days -- faste
Read more

Knockout by CRISPR vs Knockdown by shRNA

-
In solving the mystery of gene function, there is no more important clue than the phenotype of inactivating the gene of interest. With a plethora of methods available, researchers must first determine what approach is best for their specific scientific questions and experimental systems. For over a decade, RNA-interference-based methods of gene knockdown (i.e. RNAi & shRNA) have provided a wealth of insight into gene function, but in recent years the advent of CRISPR- and TALEN-based methods now allow genome editing to be used to quickly and efficiently test the effect of gene knockouts. Here, we review the advantages and disadvantages of these approaches, and describe some experimental situations in which one approach is better than another, focusing primarily on CRISPR/Cas9 and shRNA. For a discussion of the relative advantages of CRISPR/Cas9 versus TALEN , see our prior Newsletter on this topic. CRISPR Knockout In this method, a guide RNA (gRNA) homologous to an 18-22nt ta
Read more

Beyond ACE2: Additional Targets of Significance for Coronavirus Research

-
At present, the prevention and treatment of coronavirus is the most urgent issue for scientific and medical research. In addition to the ACE2 host receptor target that is being highly focused on, what other targets deserve the attention of current coronavirus researchers? Herein, experts from Cyagen investigate the lesser-known targets that are pertinent to coronavirus research, aiming to provide some helpful references to guide scientific researchers. 1. DPP4 Dipeptidyl peptidase (DPP4) belongs to the family of proline-specific serine proteases and is capable of cleaving dipeptides from the amino terminal (N-terminal). DPP4 is the most typical peptidase in this family, and it is also the third exo-peptidase that was found to be a coronavirus receptor (after ACE2 and APN). DPP4 is a multifunctional type II transmembrane glycoprotein with 766 amino acids; it exists as a homodimer on the cell surface. The dimerization of peptidase depends on the molecules’ connection between the
Read more